相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Updates from the 2020 World Health Organization Classification of Soft Tissue and Bone Tumours
William J. Anderson et al.
HISTOPATHOLOGY (2021)
Mitochondria as multifaceted regulators of cell death
Florian J. Bock et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)
Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma
Yuki Yoshimatsu et al.
HUMAN CELL (2020)
Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma
Yuki Yoshimatsu et al.
HUMAN CELL (2020)
Copanlisib promotes growth inhibition and apoptosis by modulating the AKT/FoxO3a/PUMA axis in colorectal cancer
Ji Yan et al.
CELL DEATH & DISEASE (2020)
SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma
Ilka Isfort et al.
CLINICAL CANCER RESEARCH (2019)
First-Line Therapy for Metastatic Soft Tissue Sarcoma
Megan Meyer et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2019)
Treating cancer with phosphatidylinositol-3-kinase inhibitors: increasing efficacy and overcoming resistance
Marcia N. Paddock et al.
JOURNAL OF LIPID RESEARCH (2019)
Challenges for the Clinical Development of PI3K Inhibitors: Strategies to Improve Their Impact in Solid Tumors
Ariella B. Hanker et al.
CANCER DISCOVERY (2019)
Efficacy of PI3K inhibitors in advanced breast cancer
B. Verret et al.
ANNALS OF ONCOLOGY (2019)
Establishment of novel patient-derived models of dermatofibrosarcoma protuberans: two cell lines, NCC-DFSP1-C1 and NCC-DFSP2-C1
Rieko Oyama et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2019)
Diagnosis, Prognosis, and Treatment of Alveolar Soft-Part Sarcoma A Review
Luca Paoluzzi et al.
JAMA ONCOLOGY (2019)
Establishment and proteomic characterization of patient-derived clear cell sarcoma xenografts and cell lines
Marimu Sakumoto et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2018)
Molecular Landscape in Alveolar Soft Part Sarcoma: Implications for Molecular Targeted Therapy
Mohammad Hasan Soheilifar et al.
BIOMEDICINE & PHARMACOTHERAPY (2018)
Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas
Kenji Nakano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Targeting the PI3K pathway in cancer: are we making headway?
Filip Janku et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Establishment and characterization of the NCC-SS1-C1 synovial sarcoma cell line
Fusako Kito et al.
HUMAN CELL (2018)
Idelalisib promotes Bim-dependent apoptosis through AKT/FoxO3a in hepatocellular carcinoma
Dan Yue et al.
CELL DEATH & DISEASE (2018)
Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy
John Charlson
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2018)
Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1
Rieko Oyama et al.
IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2018)
Translocation-Related Sarcomas
Kenji Nakano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Antitumor profile of the PI3K inhibitor ZSTK474 in human sarcoma cell lines
Nachi Namatame et al.
Oncotarget (2018)
Targeting B cell receptor signalling in cancer: preclinical and clinical advances
Jan A. Burger et al.
NATURE REVIEWS CANCER (2018)
BCL-2 family proteins: changing partners in the dance towards death
Justin Kale et al.
CELL DEATH AND DIFFERENTIATION (2018)
MOMP, cell suicide as a BCL-2 family business
Halime Kalkavan et al.
CELL DEATH AND DIFFERENTIATION (2018)
Application of JC1 for non-toxic isolation of cells with MDR transporter activity by flow cytometry
J. Mario Wolosin et al.
PLOS ONE (2017)
The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics
Aaron N. Hata et al.
CANCER DISCOVERY (2015)
PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting
Lauren M. Thorpe et al.
NATURE REVIEWS CANCER (2015)
Ewing's sarcoma precursors are highly enriched in embryonic osteochondrogenic progenitors
Miwa Tanaka et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
A first-in-human Phase I study of ZSTK474, an oral pan-PI3K inhibitor, in patients with advanced solid malignancies
Albert C. Lockhart et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Establishment of phosphatidylinositol 3-kinase inhibitor-resistant cancer cell lines and therapeutic strategies for overcoming the resistance
Sho Isoyama et al.
CANCER SCIENCE (2012)
ZSTK474, a specific phosphatidylinositol 3-kinase inhibitor, induces G1 arrest of the cell cycle in vivo
Shingo Dan et al.
EUROPEAN JOURNAL OF CANCER (2012)
ASPS-1, A Novel Cell Line Manifesting Key Features of Alveolar Soft Part Sarcoma
Susan Kenney et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2011)
The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells
Wei Fu et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Advances in sarcoma genomics and new therapeutic targets
Barry S. Taylor et al.
NATURE REVIEWS CANCER (2011)
Synovial Sarcoma Is a Stem Cell Malignancy
Norifumi Naka et al.
STEM CELLS (2010)
Inhibition of PI3K by ZSTK474 suppressed tumor growth not via apoptosis but G0/G1 arrest
Shingo Dan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Molecular analyses of cell origin and detection of circulating tumor cells in the peripheral blood in alveolar soft part sarcoma
Makiko Hoshino et al.
CANCER GENETICS AND CYTOGENETICS (2009)
Response to Sunitinib Malate in Advanced Alveolar Soft Part Sarcoma
Silvia Stacchiotti et al.
CLINICAL CANCER RESEARCH (2009)
The insulin-like growth factor system and sarcomas
Bart Rikhof et al.
JOURNAL OF PATHOLOGY (2009)
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
Jeffrey A. Engelman
NATURE REVIEWS CANCER (2009)
Insulin-like growth factor-I receptor acts as a growth regulator in synovial sarcoma
N. Friedrichs et al.
JOURNAL OF PATHOLOGY (2008)
Proapoptotic BH3-only BCL-2 family protein BIM connects death signaling from epidermal growth factor receptor inhibition to the mitochondrion
Jing Deng et al.
CANCER RESEARCH (2007)
Apoptosis induction in human melanoma cells by inhibition of MEK is caspase-independent and mediated by the Bcl-2 family members PUMA, Bim, and Mcl-1
Yu Fang Wang et al.
CLINICAL CANCER RESEARCH (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Antitumor activity of ZSTK474, a new phosphatidylitiositol 3-kinase inhibitor
Shin-ichi Yaguchi et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors
K Scotlandi et al.
CANCER RESEARCH (2005)
FoxO proteins in insulin action and metabolism
A Barthel et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2005)
Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: Potential application of signal inhibitors to molecular target therapy
T Ishibe et al.
CLINICAL CANCER RESEARCH (2005)
Establishment and characterization of a biphasic synovial sarcoma cell line, SYO-1
A Kawai et al.
CANCER LETTERS (2004)
p53- and drug-induced apoptotic responses mediated by BH3-only proteins Puma and Noxa
A Villunger et al.
SCIENCE (2003)
Characterization of the A673 cell line (Ewing tumor) by molecular cytogenetic techniques
A Martínez-Ramírez et al.
CANCER GENETICS AND CYTOGENETICS (2003)
Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax
H Toyota et al.
CANCER LETTERS (2003)
BID regulation by p53 contributes to chemosensitivity
JK Sax et al.
NATURE CELL BIOLOGY (2002)
PUMA induces the rapid apoptosis of colorectal cancer cells
J Yu et al.
MOLECULAR CELL (2001)
Cleavage of Bax enhances its cell death function
DE Wood et al.
EXPERIMENTAL CELL RESEARCH (2000)
分享论文
